Paul Badawi, Founder and CEO of Sight Sciences and Leon Herndon, MD, Duke University Eye Center, Durham, NC, commented on the ...

We are proud to continuously support the study of interventional glaucoma treatment, especially in highlighting critical groups of patients that may benefit from active surgical interventions. These ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A study looked at real-world outcomes with Omni, Hydrus, ...

"OMNI continues to deliver results for patients, whether it be patients undergoing cataract surgery, those that have already had cataract surgery and are now pseudophakic, or groups at historically ...

Please provide your email address to receive an email when new articles are posted on . The study enrolled patients with mild to moderate primary open-angle glaucoma who underwent canaloplasty and ...

12-Month OMNI data from the prospective, multicenter GEMINI clinical trial show statistically significant postoperative reductions in mean IOP and suppression of daily IOP fluctuations MENLO PARK, ...

Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty (ab interno), and ...

There were no serious or unanticipated adverse events during the two-year study. The study also observed an average 33% reduction in medication usage among all patients at 24 months. Don’t miss this ...

Annapolis, Md.-based Vision Innovation Partners completed its 16th post-formation transaction, acquiring Baltimore-based Omni Eye Specialists. 1. Vision will incorporate the practice into its ...

King of Prussia, Pa.-based Kremer Eye Center opened a new practice in Iselin, N.J., StreetInsider.com reports. 1. Physicians at the clinic will perform advanced custom bladeless Lasik and vision ...